What Lipoid does

Lipoid GmbH is a German specialty phospholipid manufacturer founded in 1977 and headquartered in Ludwigshafen, with approximately 500 employees operating across four cGMP-certified production plants at two German sites (Ludwigshafen and BioCampus Cologne) and eight sales and distribution offices in Germany, France, the US, Switzerland, Russia, Korea, and China. The company produces natural phospholipids (from egg, soybean, and sunflower), hydrogenated phospholipids, and highly pure synthetic phospholipids—including phosphatidylcholine, phosphatidylglycerols, phosphatidylethanolamines, phosphatidylserine, phosphatidic acids, and PEGylated or cationic lipids—as functional excipients and active ingredients for parenteral, oral, topical, pulmonary, and ocular pharmaceutical applications, as well as for nutraceutical and cosmetic end-markets. Its proprietary delivery platforms PHOSAL® (liquid phospholipid formulations in carrier oils), PhytoSolve® (emulsion-based delivery systems), and pre-formulated LIPOID Liposome® concentrates sit alongside product lines such as PHOSPHOLIPON®, SOLUTHIN®, PhytoPoor®, and SLM® Skin Lipid Matrix, protected by a portfolio of registered trademarks and supported by Drug Master Files and Active Substance Master Files for regulatory submissions.

Lipoid generates revenue through direct B2B sales of phospholipid ingredients and pre-formulated delivery systems to pharmaceutical, nutraceutical, and cosmetic manufacturers across more than 40 countries, with pricing conducted on a quote basis for pharmaceutical-grade materials. The go-to-motion is enterprise field sales augmented by technical consultation, presence at major trade shows (CPhI, Vitafoods Europe) and scientific conferences (International Symposium on Phospholipids), and content-driven marketing via its product catalog and blog. Customers span four primary verticals—pharmaceuticals (parenteral drug delivery including liposomes, micelles, and lipid nanoparticles; vaccine adjuvants), health nutrition, cosmetics (via the affiliated Lipoid Kosmetik AG), and veterinary pharmaceuticals—with the pharmaceutical segment flagged as the primary vertical. The company is controlled by the Lipoid Stiftung (Lipoid Foundation), a nonprofit foundation established in 2011. Notable milestones include involvement as a phospholipid supplier in COVID-19 mRNA vaccine lipid nanoparticle formulations and a multi-year capacity expansion at the Cologne BioCampus site, with the new production building commissioning planned for 2026.

Name

Lipoid

Legal name

Lipoid GmbH

Website

https://lipoid.com

Company type

Private

Founded year

1977

Operating status

Operating

Headcount range

11–50 employees

Short description

Lipoid is a German specialty manufacturer of natural, hydrogenated, and synthetic phospholipids serving pharmaceutical, nutraceutical, cosmetic, and veterinary manufacturers globally through four cGMP-certified German plants and eight sales offices across 40+ countries.

Ownership category

akta.pro rank

Product category

Pharmaceutical Excipients / Specialty Phospholipids

NAICS

Starch and Vegetable Fats and Oils Manufacturing (31122), Fats and Oils Refining and Blending (311225)

SIC

Fats & Oils (2070)

akta.pro primary industry

Phospholipids & Lecithin Systems (Deoiled Lecithin, Fractionated Lecithins) (AFAJALAL)

akta.pro secondary industries

Lipid-Based Emulsions & Encapsulated Oils (Spray-Dried Oils, Microencapsulation) (AFAJALAM), Encapsulation & Emulsified Delivery Systems (Spray-dried emulsions, Lipid microencapsulation) (AFAJACAL), Delivery Systems & Encapsulation (Microencapsulation, Liposomes, Emulsions, Beadlets, Spray-Dried) (AFAJAKAL), Fats, Oils & Lipid Ingredients (Specialty Oils, MCTs, Structured Lipids) (CRADAOAL)

Keywords

• Phospholipid excipients
• Lipid drug delivery
• Lecithin manufacturing
• Pharmaceutical ingredients
• Nutraceutical formulations

Headquarters

HQ city

Ludwigshafen

HQ country

Germany

HQ region

Europe

Offices10 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Pharmaceutical Phospholipid Ingredients: Sale of phospholipid ingredients to pharmaceutical manufacturers for use as excipients in drug formulations, including natural, hydrogenated, and synthetic phospholipids. Revenue generated through direct B2B sales with product consultation.
2. Phospholipid Formulation Systems: Sale of pre-formulated phospholipid delivery systems including PHOSAL®, PhytoSolve®, and liposome products for nutraceutical and pharmaceutical applications.
3. Health Nutrition Ingredients: Phospholipid products for dietary supplements and functional nutrition including sunflower-based, non-GMO soybean, and egg-derived phospholipids.
4. Cosmetic Ingredients: Phospholipid products for cosmetic applications distributed through affiliated company Lipoid Kosmetik AG.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

Lipoid manufactures and globally supplies high-purity natural, hydrogenated, and synthetic phospholipids (including phosphatidylcholine, phosphatidylethanolamines, phosphatidylserine, phosphatidylglycerols, phosphatidic acids, and cationic/PEGylated variants) used as excipients in pharmaceutical drug delivery systems such as liposomes, mixed micelles, and lipid nanoparticles. It also sells ready-to-use phospholipid formulation systems — PHOSAL® liquid carriers, PhytoSolve® emulsions, and LIPOID Liposome® pre-formulated liposomes — to pharmaceutical, nutraceutical, and cosmetic manufacturers across more than 40 countries.

Product overview

Lipoid is a leading manufacturer of phospholipids and lipid-based delivery systems for pharmaceutical, health nutrition, and cosmetic applications. The company offers a comprehensive portfolio organized into three main categories: Natural Phospholipids (sourced from egg, soybean, and sunflower), Synthetic Phospholipids (including specific chain-length phospholipids and cationic lipids), and Phospholipid Systems (including PHOSAL delivery formulations, PhytoSolve emulsions, and pre-formulated LIPOID Liposome products). These products serve as essential excipients for drug delivery systems including liposomes, mixed micelles, self-emulsifying systems, and solid dispersions. The company supplies to pharmaceutical manufacturers for parenteral, oral, topical, pulmonary, and ocular applications, as well as to nutraceutical companies for bioavailability enhancement of lipophilic nutrients.

Differentiator

Problem solved

Functional benefit

Brands

• PHOSAL®: Liquid phospholipid formulations with purified phosphatidylcholine in vegetable oil for enhanced solubility and bioavailability
• PhytoSolve®
• LIPOID Liposome®
• PHOSPHOLIPON®
• SOLUTHIN®
• PhytoPoor®
• SLM Skin Lipid Matrix®
• SLM Eco®

Products and services

• LIPOID E 80 Phospholipid ingredient with 80% phosphatidylcholine sourced from egg yolk, used as a pharmaceutical-grade excipient for liposome and drug delivery formulations.
• LIPOID E PC S Phosphatidylcholine with content ≥96.0% from egg yolk, supplied for high-purity pharmaceutical applications requiring defined and reproducible lipid composition.
• LIPOID E SM (Sphingomyelin) Sphingomyelin with content ≥98.0% sourced from egg yolk for pharmaceutical and nutritional applications including membrane and nerve-related formulations.
• LIPOID S 75 Soybean-derived phospholipid with 70% phosphatidylcholine for food and pharmaceutical applications, providing a plant-based excipient option.
• PHOSPHOLIPON 90 G Granulated phosphatidylcholine with content ≥94.0% from soybean, formulated as a pharmaceutical excipient for ease of handling in solid and liquid dosage forms.
• PHOSPHOLIPON 90 H Hydrogenated soybean phosphatidylcholine with content ≥90.0% for pharmaceutical applications requiring saturated phospholipids with improved oxidative stability.
• LIPOID H 100 Phosphatidylcholine with content ≥94.0% from non-GMO sunflower, used for clean-label nutraceutical and pharmaceutical applications.
• LIPOID H GPC sn-Glycero-3-phosphocholine with content ≥98.0% sourced from sunflower, marketed for cognitive health and nutraceutical applications.
• LIPOID PC 18:0/18:0 (DSPC) 1,2-Distearoyl-sn-glycero-3-phosphocholine synthetic phospholipid supplied for liposomal drug delivery systems and pharmaceutical formulations requiring defined saturated chains.
• LIPOID DOTAP-CI 1,2-Dioleoyloxy-3-trimethylammonium-propane chloride synthetic cationic lipid supplied for mRNA vaccine lipid nanoparticle delivery and gene therapy applications.
• PHOSAL MCT Liquid phospholipid formulation containing 30% LIPOID S 75 in medium-chain triglycerides, designed to enhance solubility and bioavailability in pharmaceutical and nutritional formulations.
• PHOSAL Curcumin Phosphatidylcholine in medium-chain triglycerides loaded with 7% curcumin, marketed as a phospholipid delivery system with enhanced curcumin bioavailability and bioactivity.
• PhytoSolve Q10 Phospholipid emulsion containing 5% coenzyme Q10, formulated as a water-soluble supplement delivery system that enables clear beverages and liquid supplement formats.
• PhytoSolve ADEK Phospholipid emulsion combining lipophilic vitamins A, D3, E, and K2 in a single water-soluble formulation using PhytoSolve technology to enhance bioavailability in nutraceutical products.
• LIPOID Liposome Basic

Quantifiable outcome

• Market leader in pharmaceutical phospholipids with involvement in COVID-19 mRNA vaccines
• +1 more outcomes

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• Phospholipid Research CentercoreStrategic or Co-development PartnerIndependent phospholipid research center supported by Lipoid GmbH and PHOSPHOLIPID GmbH. The center fosters exchange between science and industry in phospholipid research and is described as part of Lipoid's value chain.

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Cargill:
• Croda International: Croda International is a large specialty chemicals incumbent that, through its acquisition of Avanti Polar Lipids and broader Pharma division, supplies phospholipid excipients alongside a wide portfolio of cosmetic and nutraceutical ingredients. Comparable as a broader pharma excipient supplier with overlapping phospholipid capabilities.
• Evonik Industries: Evonik is a major specialty chemicals incumbent that supplies pharmaceutical excipients and lipid-based delivery systems (including liposomal and lipid nanoparticle components) to global drug developers. Comparable as a large-scale GMP excipient manufacturer with adjacent lipid capabilities to Lipoid's portfolio.

Direct peers

• NOF Corporation: NOF Corporation is a Japanese specialty chemical manufacturer producing high-purity phospholipids and PEG-lipids for pharmaceutical applications, including mRNA vaccine delivery. It competes directly with Lipoid in synthetic and hydrogenated phosphatidylcholine products for global pharma customers.
• Avanti Polar Lipids: Avanti Polar Lipids (now part of Croda) is one of the closest direct peers to Lipoid, specializing in high-purity natural and synthetic phospholipids for pharmaceutical and research use. Both companies compete head-to-head in lipid excipients for liposomal drug delivery and lipid nanoparticle formulations.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/LipoidDeutschland
• LinkedInlinkedin.com/company/lipoid

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lipoid